Organigram Global Inc.
OGI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001620737
No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.
Holders of 5% or more of OGI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Organigram Global Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BT DE Investments Inc. | 13D/A | 29.70%40.1M shares | −0.30 ppfrom 30.00% | Mar 3, 20252 filings | Feb 20, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Organigram Global Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 20265:26 PM ET | BT DE Investments Inc.and 1 other | 13D/A | 29.70%40.1M shares | −0.30 ppfrom 30.00% | Feb 18, 2026 | SEC |
| Mar 3, 20256:16 PM ET | BT DE Investments Inc.and 1 other | 13D/A | 30.00%40.1M shares | – | Feb 28, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Organigram Global Inc. shares.
No Form 144 notices for Organigram Global Inc. are on file.